AcquisitionOther

CHEMBIO DIAGNOSTICS, INC. acquired Chembio Diagnostics, Inc

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

CHEMBIO DIAGNOSTICS, INC. -> Chembio Diagnostics, Inc · $0.45

STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced it has completed its acquisition of Chembio Diagnostics, Inc.

Open source record (SEC) ↗